Adrenergic beta-receptor blockers, adrenalin and intraocular pressure.
D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001262:Atenolol / Q000009:adverse effects / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004837:Epinephrine / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000009:adverse effects / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects; D011897:Random Allocation; D013999:Timolol / Q000009:adverse effects / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D004338:Drug Combinations; D001262:Atenolol; D013999:Timolol; D011433:Propranolol; D004837:Epinephrine